Below are the most recent publications written about "Neuromuscular Blocking Agents" by people in Profiles.
-
DeMasi SC, Self WH, Aggarawal NR, April MD, Andrea L, Barnes CR, Brainard J, Blinder V, Dagan A, Driver B, Doerschug KC, Douglas I, Exline M, Fein DG, Gaillard JP, Gandotra S, Gibbs KW, Ginde AA, Halliday SJ, Han JH, Herbert T, High K, Hughes CG, Khan A, Latimer AJ, Maiga AW, Mitchell SH, Muhs AL, Mohamed A, Moskowitz A, Page DB, Palakshappa JA, Prekker ME, Qian ET, Resnick-Ault D, Rice TW, Russel DW, Schauer SG, Seitz KP, Shapiro NI, Smith LM, Sottile P, Stempek S, Trent SA, Vonderhaar DJ, Walker JE, Wang L, Whitson MR, Casey JD, Semler MW. Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials. Ann Emerg Med. 2025 Jan; 85(1):6-13.
-
Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J, Bellani G, Brower RG, Burry L, Chen JT, Hodgson C, Hough CL, Lamontagne F, Law A, Papazian L, Pham T, Rubin E, Siuba M, Telias I, Patolia S, Chaudhuri D, Walkey A, Rochwerg B, Fan E. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 01 01; 209(1):24-36.
-
Murray MJ, DeBlock HF, Erstad BL, Gray AW, Jacobi J, Jordan CJ, McGee WT, McManus C, Meade MO, Nix SA, Patterson AJ, Sands K, Pino RM, Tescher AN, Arbour R, Rochwerg B, Murray CF, Mehta S. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update-executive summary. Am J Health Syst Pharm. 2017 Jan 15; 74(2):76-78.
-
Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, McGee W, McManus C, Meade M, Nix S, Patterson A, Sands MK, Pino R, Tescher A, Arbour R, Rochwerg B, Murray CF, Mehta S. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. Crit Care Med. 2016 Nov; 44(11):2079-2103.
-
Wilcox SR. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review. J Crit Care. 2017 02; 37:149-155.
-
Chong ID, Sandefur BJ, Rimmelin DE, Arbelaez C, Brown CA, Walls RM, Pallin DJ. Long-acting neuromuscular paralysis without concurrent sedation in emergency care. Am J Emerg Med. 2014 May; 32(5):452-6.
-
Steingrub JS, Lagu T, Rothberg MB, Nathanson BH, Raghunathan K, Lindenauer PK. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis. Crit Care Med. 2014 Jan; 42(1):90-6.
-
Wilcox SR, Bittner EA, Elmer J, Seigel TA, Nguyen NT, Dhillon A, Eikermann M, Schmidt U. Neuromuscular blocking agent administration for emergent tracheal intubation is associated with decreased prevalence of procedure-related complications. Crit Care Med. 2012 Jun; 40(6):1808-13.
-
Cooper MK, Bateman ST. Cisatracurium in "weakening doses" assists in weaning from sedation and withdrawal following extended use of inhaled isoflurane. Pediatr Crit Care Med. 2007 Jan; 8(1):58-60.
-
Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA, Lumb PD. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002 Jan; 30(1):142-56.